Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sussman

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2013
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitisA Didier, H-J Malling, M Worm, et al.
Journal of Toxicology and Environmental Health|March 1, 1983
Repeated pulmonary function evaluation following bleomycin treatmentR J Jaeger, R G Sussman, J M Gearhart, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1995
A collaborative evaluation of seven alternatives to the Draize eye irritation test using pharmaceutical intermediatesJ F Sina, D M Galer, R G Sussman, et al.
Journal of Immunotoxicology|October 30, 2008
Identification of phenolic dermal sensitizers in a wound closure tapeL P Myers, B F Law, A Fedorowicz, et al.
Research and Practice in Thrombosis and Haemostasis|April 12, 2024
Constitutive hypercoagulability in pediatric sickle cell disease patients with hemoglobin SS genotypeRaizl G Sussman, Joy Mburu, MacGregor Steele, et al.
Regulatory Toxicology and Pharmacology : RTP|May 29, 2016
Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaningMichael J Olson, Ellen C Faria, Eileen P Hayes, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2016
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerationsEileen P Hayes, Robert A Jolly, Ellen C Faria, et al.
Allergy|April 3, 2016
Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and ExcellenceM Maurer, M Metz, C Bindslev-Jensen, et al.
Allergy|May 26, 2017
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSUM Maurer, M Abuzakouk, F Bérard, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 23, 2013
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitisA Didier, H-J Malling, M Worm, et al.
Journal of Toxicology and Environmental Health|March 1, 1983
Repeated pulmonary function evaluation following bleomycin treatmentR J Jaeger, R G Sussman, J M Gearhart, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1995
A collaborative evaluation of seven alternatives to the Draize eye irritation test using pharmaceutical intermediatesJ F Sina, D M Galer, R G Sussman, et al.
Journal of Immunotoxicology|October 30, 2008
Identification of phenolic dermal sensitizers in a wound closure tapeL P Myers, B F Law, A Fedorowicz, et al.
Research and Practice in Thrombosis and Haemostasis|April 12, 2024
Constitutive hypercoagulability in pediatric sickle cell disease patients with hemoglobin SS genotypeRaizl G Sussman, Joy Mburu, MacGregor Steele, et al.
Regulatory Toxicology and Pharmacology : RTP|May 29, 2016
Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaningMichael J Olson, Ellen C Faria, Eileen P Hayes, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2016
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerationsEileen P Hayes, Robert A Jolly, Ellen C Faria, et al.
Allergy|April 3, 2016
Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and ExcellenceM Maurer, M Metz, C Bindslev-Jensen, et al.
Allergy|May 26, 2017
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSUM Maurer, M Abuzakouk, F Bérard, et al.
Pageof 6